🔎 Trials Near Me

Utama › Penyakit Paru-paru › Nevada

Kajian klinikal Penyakit Paru-paru di Nevada

6 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi di Nevada.

Bandar di Nevada

Teks kajian rasmi (Bahasa Inggeris)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Las Vegas Clinical Trials, North Las Vegas
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Henderson Clinical Trials, Henderson
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06977581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Comprehensive Cancer Centers of Nevada, Las Vegas
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Renown Regional Medical Center, Reno
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • Comprehensive Cancer Centers of Nevada - Central Valley - Twain, Las Vegas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT05967689

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

  • PPD - Las Vegas Research Unit, Las Vegas
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07745907

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.